Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Paclitaxel, Carboplatin, and Topotecan in Patients With Ovarian Cancer

This study has been completed.
Information provided by:
AGO Study Group Identifier:
First received: January 29, 2005
Last updated: August 3, 2006
Last verified: February 2006